ApprovalTrail

Approval · Notice of Compliance 30841 · 2023

FLAGYL: Notice of Compliance 30841

Issued May 24, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
30841
Date
May 24, 2023
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Administrative: Change in Product Ownership

Products in this notice

BrandDINStatus today
FLAGYL01926853Cancelled Pre Market

Medicinal ingredients